These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32171723)

  • 21. Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
    Mohammadi F; Hashemi SJ; Zoll J; Melchers WJ; Rafati H; Dehghan P; Rezaie S; Tolooe A; Tamadon Y; van der Lee HA; Verweij PE; Seyedmousavi S
    Antimicrob Agents Chemother; 2016 Jan; 60(1):387-92. PubMed ID: 26525787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary laryngeal aspergillosis in the immunocompetent state: a clinical update.
    Dutta M; Jotdar A; Kundu S; Ghosh B; Mukhopadhyay S
    Braz J Otorhinolaryngol; 2017; 83(2):228-234. PubMed ID: 26712632
    [No Abstract]   [Full Text] [Related]  

  • 23. Disseminated invasive aspergillosis in an apparently immunocompetent host.
    Raja NS; Singh NN
    J Microbiol Immunol Infect; 2006 Feb; 39(1):73-7. PubMed ID: 16440127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients.
    Fuhren J; Voskuil WS; Boel CH; Haas PJ; Hagen F; Meis JF; Kusters JG
    J Antimicrob Chemother; 2015 Oct; 70(10):2894-8. PubMed ID: 26163402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First itraconazole resistant Aspergillus fumigatus clinical isolate harbouring a G54E substitution in Cyp51Ap in South America.
    Leonardelli F; Theill L; Nardin ME; Macedo D; Dudiuk C; Mendez E; Gamarra S; Garcia-Effron G
    Rev Iberoam Micol; 2017; 34(1):46-48. PubMed ID: 28087293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An alternative host model of a mixed fungal infection by azole susceptible and resistant Aspergillus spp strains.
    Alcazar-Fuoli L; Buitrago M; Gomez-Lopez A; Mellado E
    Virulence; 2015; 6(4):376-84. PubMed ID: 26065322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.
    Chowdhary A; Sharma C; Hagen F; Meis JF
    Future Microbiol; 2014; 9(5):697-711. PubMed ID: 24957095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular assay to detect nosocomial fungal infections in intensive care units.
    Badiee P; Alborzi A; Joukar M
    Eur J Intern Med; 2011 Dec; 22(6):611-5. PubMed ID: 22075290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspergillus species collected from environmental air samples in Portugal-molecular identification, antifungal susceptibility and sequencing of cyp51A gene on A. fumigatus sensu stricto itraconazole resistant.
    Monteiro C; Pinheiro D; Maia M; Faria MA; Lameiras C; Pinto E
    J Appl Microbiol; 2019 Apr; 126(4):1140-1148. PubMed ID: 30735287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspergillus fumigatus isolated from blood samples of a patient with pulmonary aspergilloma after embolization.
    Seki M; Maesaki S; Hashiguchi K; Tomiyama Y; Tomono K; Tashiro T; Kohno S
    Intern Med; 2000 Feb; 39(2):188-90. PubMed ID: 10732844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidrug resistance in Aspergillus fumigatus.
    Warris A; Weemaes CM; Verweij PE
    N Engl J Med; 2002 Dec; 347(26):2173-4. PubMed ID: 12501236
    [No Abstract]   [Full Text] [Related]  

  • 32. Multi-azole resistant Aspergillus fumigatus harboring Cyp51A TR46/Y121F/T289A isolated in Japan.
    Hagiwara D; Takahashi H; Fujimoto M; Sugahara M; Misawa Y; Gonoi T; Itoyama S; Watanabe A; Kamei K
    J Infect Chemother; 2016 Aug; 22(8):577-9. PubMed ID: 26898666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany.
    Hamprecht A; Buchheidt D; Vehreschild JJ; Cornely OA; Spiess B; Plum G; Halbsguth TV; Kutsch N; Stippel D; Kahl P; Persigehl T; Steinbach A; Bos B; Hallek M; Vehreschild MJ
    Euro Surveill; 2012 Sep; 17(36):20262. PubMed ID: 22971327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus.
    Warn PA; Sharp A; Morrissey G; Denning DW
    Int J Antimicrob Agents; 2010 Feb; 35(2):146-51. PubMed ID: 20015618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudallescheria boydii with Aspergillus fumigatus and Aspergillus terreus in a Critically Ill Hematopoietic Stem Cell Recipient with ARDS.
    Lahmer T; Messer M; Ehmer U; Eser S; Beitz A; Fekecs L; Schmid RM; Huber W
    Mycopathologia; 2016 Apr; 181(3-4):267-71. PubMed ID: 26455910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism.
    Snelders E; van der Lee HA; Kuijpers J; Rijs AJ; Varga J; Samson RA; Mellado E; Donders AR; Melchers WJ; Verweij PE
    PLoS Med; 2008 Nov; 5(11):e219. PubMed ID: 18998768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of voriconazole in a patient with aspergilloma caused by an itraconazole-resistant strain of Aspergillus fumigatus.
    Dannaoui E; Garcia-Hermoso D; Naccache JM; Meneau I; Sanglard D; Bouges-Michel C; Valeyre D; Lortholary O
    J Med Microbiol; 2006 Oct; 55(Pt 10):1457-1459. PubMed ID: 17005798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous purulent aspergillosis in a young man with chronic granulomatous disease.
    Chatzipanagiotou S; Takou K; Perogamvros A
    Mycoses; 1998 Nov; 41(9-10):379-82. PubMed ID: 9916460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Itraconazole resistance in Aspergillus fumigatus.
    Denning DW; Venkateswarlu K; Oakley KL; Anderson MJ; Manning NJ; Stevens DA; Warnock DW; Kelly SL
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1364-8. PubMed ID: 9174200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibility to five antifungals of Aspergillus fumigatus strains isolated from chronically colonised cystic fibrosis patients receiving azole therapy.
    Amorim A; Guedes-Vaz L; Araujo R
    Int J Antimicrob Agents; 2010 Apr; 35(4):396-9. PubMed ID: 20138740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.